Germany has submitted a restriction intention on the manufacture and placing on the market of undecafluorohexanoic acid (PFHxA), its salts and related substances (EC -). The expected submission date for the dossier is 27 September 2019.
ECHA's committees are currently performing conformity checks on the dossiers. The dossiers will be published on ECHA's website on 30 January, to ensure transparency and that stakeholders have enough time to prepare for the six-month public consultations. The public consultations will start in April 2019 if the dossiers pass conformity.
Authorisations granted for various uses of three substances
The European Commission has granted authorisations for seven uses related to three substances. The authorisations (expiry date of review period given in brackets) are for:
bis(2-methoxyethyl) ether (diglyme) (EC 203-924-4; CAS 111-96-6), granted to Maflon SpA (22 August 2029) -details;
chromium trioxide (EC 215-607-8; CAS 1333-82-0), granted to Euro Cryospace France (21 September 2024) -details;
chromium trioxide (EC 215-607-8; CAS 1333-82-0), granted to Circuit Foil Luxembourg SARL (21 September 2024) -details;
chromium trioxide (EC 215-607-8; CAS 1333-82-0), granted to FN Herstal SA, Manroy Engineering Ltd and Browning Viana Fabrica de Armas e Artigos de Desporto SA (21 September 2029; 21 September 2024) -details;
1,2-dichloroethane (EDC) (EC 203-458-1; CAS 107-06-2), granted to emp Biotech GmbH (22 November 2029) -details; and
1,2-dichloroethane (EDC) (EC 203-458-1; CAS 107-06-2), granted to Grupa Lotos SA (22 November 2029) -details.
Introductory Guidance on the CLP Regulation updated
ECHA has published an updated version of its Introductory Guidance on the CLP Regulation (version 3.0).
The update takes into account the changes to the regulation brought by the latest Adaptations to Technical and Scientific Progress (ATPs), including the 12th ATP. Outdated information has also been deleted.
The Board of Appeal has published a decision in case A-004-2017. The appeal concerns a substance evaluation decision on UVASORB HEB (EC 421-450-8).
The Appellant challenged the request to perform an OECD TG 308 study and provide further information on uses and environmental emissions.
The Board of Appeal found that the Agency had grounds for requesting information on the OECD TG 308 study and dismissed that part of the appeal. The requirement to provide further information on uses and environmental emissions was annulled.